Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease
Information & Authors
Information
Published In
Copyright
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Publication History
Received: July 9, 2021
Accepted: November 30, 2021
Published online: January 12, 2022
Published in print: February 22, 2022
Disclosure
R. Takahashi reports grants and personal fees from Takeda Pharma, Boeringer Ingelheim, Dainippon Sumito Pharma, Kyowa-Kirin Pharma, Eisai Pharma, Otsuka Pharma, Novartis, Sanofi, Kan Institute, and Nihon Medi-physics; grants from Astellas Pharma; personal fees from Abbvie, Mylan, JBO, Sanwa Kagaku, FP Pharma, Tsumura, Kissei, Chugai Pharma, and Biogen, outside the submitted work. The remaining authors (K. Tsukita and H. Sakamaki-Tsukita) report no disclosures. Go to Neurology.org/N for full disclosures.
Study Funding
This work was supported by JST [Moonshot R&D] [Grant Number JPMJMS2024].
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Treatment of Apathy in Parkinson’s Disease and Implications for Underlying Pathophysiology, Journal of Clinical Medicine, 13, 8, (2216), (2024).https://doi.org/10.3390/jcm13082216
- A Comprehensive Approach to Parkinson’s Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects, International Journal of Molecular Sciences, 25, 13, (7183), (2024).https://doi.org/10.3390/ijms25137183
- The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology, International Journal of Molecular Sciences, 25, 8, (4358), (2024).https://doi.org/10.3390/ijms25084358
- Exercise, Neuroprotective Exerkines, and Parkinson’s Disease: A Narrative Review, Biomolecules, 14, 10, (1241), (2024).https://doi.org/10.3390/biom14101241
- MoveONParkinson: developing a personalized motivational solution for Parkinson’s disease management, Frontiers in Public Health, 12, (2024).https://doi.org/10.3389/fpubh.2024.1420171
- Considerations on How to Prevent Parkinson’s Disease Through Exercise, Journal of Parkinson's Disease, 14, s2, (S395-S406), (2024).https://doi.org/10.3233/JPD-240091
- Digital Intervention Promoting Physical Activity in People Newly Diagnosed with Parkinson’s Disease: Feasibility and Acceptability of the Knowledge, Exercise-Efficacy and Participation (KEEP) Intervention, Journal of Parkinson's Disease, 14, 6, (1193-1210), (2024).https://doi.org/10.3233/JPD-240071
- Parkinson’s Disease is Predominantly a Genetic Disease, Journal of Parkinson's Disease, 14, 3, (467-482), (2024).https://doi.org/10.3233/JPD-230376
- Dietary Interventions in Parkinson’s Disease, Journal of Parkinson's Disease, 14, 1, (1-16), (2024).https://doi.org/10.3233/JPD-230366
- Alleviating Stress in Parkinson’s Disease: Symptomatic Treatment, Disease Modification, or Both?, Journal of Parkinson's Disease, 14, s1, (S147-S158), (2024).https://doi.org/10.3233/JPD-230211
- See more
Loading...
View Options
View options
PDF and All Supplements
Download PDF and Supplementary MaterialShort Form
View Short FormFull Text HTML
View Full Text HTMLLogin options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.
We thank Dr. Grippe and colleagues for the constructive comment on our article.1 Along with highlighting important references,2,3 they reasonably urged caution in the interpretation of our results based on the inherent limitation of observational studies that "reverse causation" cannot be ruled out. These authors also note concern for the use of the Physical Activity Scale for the Elderly questionnaire to quantify regular physical activity and exercise habits. We fully agree with these points.
We believe that the only way to overcome these two limitations is to conduct a well-designed intervention trial combined with objective monitoring of exercise intensity. Although our study only examined association, we believe it provides important indications of the importance of maintaining physical activity, and the possibility that different physical activities may be beneficial for different clinical symptoms. We hope that the results of our study will help guide future trials to place emphasis on continuous exercise, which is possible now that internet-based applications are developed and widespread,4,5 as well as the differential effects of exercise.
Disclosure
The authors report no relevant disclosures. Contact [email protected] for full disclosures.
References
We thank Dr. Gupta for the comment on our article,1 which requested further elucidation of the biological basis of the effect of exercise, especially in relation to α-synuclein toxicity.2 The comment also highlighted the importance of motivation for continued engagement in physical activities.
The results of our study support the long-term effects of exercise, although the possibility of reverse causality cannot be denied. Whether these effects are "symptomatic" or "disease-modifying" warrants further studies in future. In this respect, further clinical trials with a delayed-start design, imaging studies exploring changes in the brain network after exercise, and animal studies exploring the effect of exercise on disease-relevant changes in Parkinson disease (PD) including α-synuclein pathology are important.3-5
In addition, we believe that future research should clarify the impact of different motivations for exercise in the course of PD and strategies to support long-term motivation of PD patients; for example, through remote supervision using mobile applications. We hope that further research in this direction will eventually lead to the establishment of strategies that enable PD patients to live better lives through physical activity and exercise.
Disclosure
The authors report no relevant disclosures. Contact [email protected] for full disclosures.
References
We thank Darweesh et al. for their comment on our article.1 Due to the observational nature of our study, the possibility of reverse causality or that it reflects a symptomatic effect cannot be denied. However, in light of the recent highlighted evidence,2 it is quite possible that the results demonstrate the disease-modifying effects of physical activities. In addition to our study, a recent study showed that exercise may change the brain network to some extent, thus providing additional support for the possible disease-modifying effects of exercise and physical activities.3
We hope that this study will motivate patients with Parkinson's disease to keep engaging in physical activities and inspire future randomized clinical trials (RCTs) to focus on sustained exercise, for example, via remote supervision.2,4 We also hope that in the future those RCTs will include many ethnic groups through international multi-center studies,5 and a way to modify the pathogenesis of PD and delay its onset through exercise and physical activities will eventually be found for PD patients and "prodromal" subjects all over the world.
Disclosure
The authors report no relevant disclosures. Contact [email protected] for full disclosures.
References
Dr. Tsukita and colleagues’ PPMI database analysis reports the effects of physical activity on the progression of PD clinical parameters, measured using the Physical Activity Scale for the Elderly (PASE). It confirms prior studies showing that regular exercise is associated with improved outcomes.2 Although the study uses rigorous statistical methods, the reported association between maintained physical activity and concurrent slower deterioration of postural and gait stability should be interpreted carefully.
The authors emphasize the mechanisms by which exercise may improve outcomes; the title implies causation. However, impaired postural and gait stability are well known to affect physical activity in PD.3 Many of the activities listed in the PASE require good balance. Thus, postural and gait impairments could be responsible for reducing exercise. We believe this reverse causation is a critical factor to consider before assuming that the reduced rate of posture and gait deterioration is a direct effect of the amount and regularity of the exercise performed.
Additionally, the PASE questionnaire, based on a 1-week recall, is limited by lower reliability than questionnaires with longer timeframes and only moderate correlation with objective activity monitoring in people with PD.4,5 Psychometrically strong, clinical measures of physical activity are needed.
Disclosure
The authors report no relevant disclosures. Contact [email protected] for full disclosures.
References
Tsukita et al. emphasize the value of regular physical activity and exercise habits for improving the clinical course of Parkinson disease (PD), with each type of physical activity offering different benefits. Their study also recommends a change in attitude towards exercise as therapy.1
In the absence of further evolution of the interrelated pathophysiologic processes linked to PD, exercise (like stress) remains a mechanistic euphemism.2 The greater the lack of clarity on related alteration of pathophysiological mechanisms, the more attractive the therapeutic role for exercise (high/low impact) becomes.2,3 Even randomized controlled trials or meta-analyses including exercise do not supplant the need for the therapy to be placed in a biologically-plausible, overarching theoretical matrix.3,4 In order for exercise to emerge as a scientifically valid therapy for non-motor and motor symptoms of PD, it is essential to maintain hyperfocus on toxicity and the spread of α-synuclein.
Motivation is a key factor for evaluating benefits of staying physically active in health and disease.5 Basal and stimulated motivation for exercise varies widely between individuals. Comparison of a cohort of PD patients with and without motivation profile for a particular physical exercise is important to critically differentiate the value of such therapy.5
Disclosure
The author reports no relevant disclosures. Contact [email protected] for full disclosures.
References
The study by Tsukita et al. explores the prolonged benefits of vigorous exercise for patients with Parkinson Disease over long intervals (>5 years).1 This research builds on two recent trials, which demonstrate that engaging in vigorous exercise stabilizes the clinical progression of Parkinson’s Disease (PD) over 6 months.2,3 The study also suggests that maintaining a high total volume of physical activities, even at low intensity, may yield additional benefits.
Since this was not a randomized controlled trial, some of the observed associations may reflect reverse causality. However, taken together with the results from animal models, previous observational studies, and two clinical trials, there is now converging evidence that regularly engaging in exercise may slow the progression of PD.4 This should not only motivate people with PD to be physically active, but could also open up avenues for prevention of PD.
Prospective studies show that vigorous exercise and a high total volume of physical activities are both associated with a reduced risk of PD.5 A possible explanation is that exercise may slow the pathological processes of PD already during the decade-long prodromal phase of the disease. The findings by Tsukita et al. should inspire intervention studies for patients suspected of having prodromal PD, to determine whether regular exercise over long intervals may prevent or delay the manifestation of overt clinical symptoms of PD.
Disclosure
The authors report no relevant disclosures. Contact [email protected] for full disclosures.
References